Home › Department of Health and Human Services › Contract 75N93019C00052
UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
Federal contract 75N93019C00052 with Department of Health and Human Services, currently held by UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC..
Expires 2027-09-09 · in 13 months
- Incumbent
- UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
- Awarding agency
- Department of Health and Human Services
- Sub-agency
- National Institutes of Health
- Industry (NAICS)
- 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Ceiling value
- $76,786,980
- Period of performance
- 2019-09-10 to 2027-09-09
- Award ID
- 75N93019C00052
Contract description
COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST AND BROADLY PROTECTIVE IMMU
Recompete context. This contract's current period of performance ends on
2027-09-09 (in 13 months). When a period of performance ends, the
agency typically either recompetes the work, extends the incumbent, or exercises a remaining option.
An end date is the earliest reliable public signal that a follow-on may be coming, which is why capture
teams track it. It is not a guarantee of a recompete. All figures are drawn from
USAspending.gov (U.S. Treasury) and are public domain.
Other Department of Health and Human Services contracts on the cliff
| Incumbent | Ceiling value | Ends | Expiry |
|---|---|---|---|
| NOVITAS SOLUTIONS, INC. | $921,080,482 | 2026-08-31 | expiring now |
| VERIZON BUSINESS NETWORK SERVICES LLC | $406,353,536 | 2026-08-31 | expiring now |
| LEIDOS BIOMEDICAL RESEARCH INC | $371,787,375 | 2026-08-30 | expiring now |
| LEIDOS, INC. | $152,046,866 | 2026-08-31 | expiring now |
| LEIDOS BIOMEDICAL RESEARCH INC | $87,806,507 | 2026-08-30 | expiring now |
| LEIDOS BIOMEDICAL RESEARCH INC | $80,917,684 | 2026-08-31 | expiring now |